Cancer Genetics and Epigenetics 2024, Vol.12, No.3, 125-136 http://medscipublisher.com/index.php/cge 136 Tsimberidou A.M., Fountzilas E., Nikanjam M., and Kurzrock R., 2020, Review of precision cancer medicine: evolution of the treatment paradigm, Cancer Treatment Reviews, 86: 102019. https://doi.org/10.1016/j.ctrv.2020.102019 Wakai T., Prasoon P., Hirose Y., Shimada Y., Ichikawa H., and Nagahashi M., 2019, Next-generation sequencing-based clinical sequencing: toward precision medicine in solid tumors, International Journal of Clinical Oncology, 24: 115-122. https://doi.org/10.1007/s10147-018-1375-3 Wang H., 2019, Genomic-guided individualized precision therapy in refractory metastatic solid tumor patients with extensively poor performance status: a chinese single institutional prospective observational real-world study, Annals of Oncology, 30: v765. https://doi.org/10.1093/annonc/mdz268.012 Yadav S.S., Chauhan V., Singh V., and Kohler S., 2024, The role of genetic data analysis for precision therapy in cancer, Diagnostic Applications of Health Intelligence, 4: 127-143. https://doi.org/10.4018/978-1-7998-6527-8.ch006 Yi S., and Sahni N., 2017, Regulome networks and mutational landscape in liver cancer: an informative path to precision medicine, Hepatology, 66(1): 280-282. https://doi.org/10.1002/hep.29220 Zugazagoitia J., Guedes C., Ponce S., Ferrer I., Molina-Pinelo S., and Paz-Ares L., 2016, Current challenges in cancer treatment, Clinical Therapeutics, 38(7): 1551-1566. https://doi.org/10.1016/j.clinthera.2016.03.026
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==